Financial Performance - The company's revenue for Q1 2019 was ¥4,839,082,160.07, representing a 27.73% increase compared to ¥3,788,463,600.14 in the same period last year[7] - Net profit attributable to shareholders was ¥98,737,958.33, up 12.48% from ¥87,784,300.11 year-on-year[7] - The net profit after deducting non-recurring gains and losses was ¥98,246,179.84, reflecting a 13.26% increase from ¥86,747,665.03 in the previous year[7] - Basic earnings per share rose to ¥0.39, an increase of 11.43% from ¥0.35 in the previous year[7] - Net profit for Q1 2019 was ¥160,508,634.40, up 13.3% from ¥141,671,151.77 in the same period last year[38] - The company's operating revenue for the current period reached ¥1,288,541,136.38, an increase from ¥1,168,031,268.30 in the previous period, reflecting a growth of approximately 10.3%[41] - The net profit for the current period was ¥52,489,190.13, compared to ¥41,924,702.07 in the previous period, indicating a year-over-year increase of about 25.5%[42] - Basic and diluted earnings per share for Q1 2019 were both ¥0.39, an increase from ¥0.35 in Q1 2018[39] Assets and Liabilities - The company's total assets increased by 8.73% to ¥11,797,198,848.29 from ¥10,850,365,413.55 at the end of the previous year[7] - The total assets as of March 31, 2019, amounted to CNY 11.80 billion, compared to CNY 10.85 billion at the end of 2018, reflecting an increase of CNY 949.83 million[28] - The total liabilities as of March 31, 2019, were CNY 7.89 billion, an increase from CNY 7.12 billion at the end of 2018, indicating a growth of CNY 771.65 million[29] - The total equity as of March 31, 2019, was CNY 3.91 billion, compared to CNY 3.73 billion at the end of 2018, showing an increase of CNY 173.18 million[30] - The company reported a total liability of ¥3,468,939,556.58, which is an increase of 8.5% from ¥3,197,196,768.66 in the previous period[34] - The company’s total equity reached ¥2,077,672,276.35, up from ¥2,025,183,086.22, indicating a growth of 2.6%[35] Cash Flow - The net cash flow from operating activities was -¥50,182,482.22, an improvement of 90.61% compared to -¥534,629,181.86 in the same period last year[7] - The net cash flow from operating activities increased by CNY 484.45 million, a growth of 90.61%, attributed to enhanced management of accounts receivable and significant cash collection compared to the previous year[18] - The net cash flow from operating activities was -¥164,563,895.68, an improvement from -¥237,601,220.73 in the previous year[50] - The company reported cash inflows from financing activities of ¥1,614,006,347.99, up from ¥988,952,763.90 in the previous period, showing a significant increase of about 63.1%[47] - Total cash inflow from financing activities reached ¥1,489,669,739.94, compared to ¥1,269,132,118.90 in the same period last year, marking an increase of approximately 17.3%[51] Operational Expenses - The sales expenses increased by CNY 62.58 million, a growth of 58%, mainly due to increased freight and labor costs associated with business growth[18] - The total operating expenses increased, with sales expenses at ¥34,617,498.41 and management expenses at ¥16,536,001.15, compared to the previous period's figures[41] - The company incurred financial expenses of ¥6,300,655.68, which is an increase from ¥5,099,240.77 in the previous period[41] Shareholder Information - The company has a total of 21,731 common shareholders as of the end of the reporting period[11] - China Youth Industrial Development Corporation holds 16.72% of the company's shares, with 10,650,000 shares pledged[15] Investments - The company acquired 51% of Zhejiang Jia Shi Tong Han Biotechnology Co., Ltd. for a cash consideration of ¥43,758,000.00, with an outstanding payment of ¥35,006,400.00 as of March 31, 2019[16] Other Financial Metrics - The weighted average return on equity was 3.88%, slightly down from 3.90% year-on-year[7] - The investment income decreased by CNY 0.31 million, a decline of 98.24%, primarily due to reduced income from structured deposits[18] - The other income decreased by CNY 1.19 million, a decline of 44.9%, mainly due to a reduction in government subsidies received by subsidiaries compared to the previous year[18] - The amount of employee compensation payable decreased by CNY 24.74 million, a decline of 67.56%, primarily due to the distribution of last year's accrued year-end bonuses during the reporting period[18] Cash Management - The cash and cash equivalents at the end of the reporting period increased by CNY 469.10 million, a growth of 43.43%, mainly due to improved management of accounts receivable and increased cash collection[18] - Cash and cash equivalents increased significantly to ¥448,898,056.93 from ¥217,660,638.33, marking a growth of 106.5%[32] - Cash and cash equivalents at the end of the period increased to ¥1,404,768,049.21 from ¥1,119,988,926.60, marking a rise of approximately 25.4%[47] - The cash and cash equivalents at the end of the period amounted to ¥448,898,056.93, slightly up from ¥445,062,312.31 year-over-year[51] Reporting Standards - The company has implemented new financial instrument standards and reporting formats effective January 1, 2019, impacting the classification of certain financial assets[57] - The first quarter report for 2019 was not audited[58]
嘉事堂(002462) - 2019 Q1 - 季度财报